Exclusive

Publication

Byline

Location

US Patent Issued to SAISEI PHARMA on April 21 for "Senescence inhibitor" (Japanese Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,421, issued on April 21, was assigned to SAISEI PHARMA Co. LTD. (Osaka, Japan). "Senescence inhibitor" was invented by Toshio Inui (Osaka,... Read More


US Patent Issued to S.I.S SHULOV INNOVATIVE SCIENCE on April 21 for "Compositions and methods for treating degenerative, age-related and trauma-induced disorders" (Israeli Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,422, issued on April 21, was assigned to S.I.S SHULOV INNOVATIVE SCIENCE LTD. (Rehovot, Israel). "Compositions and methods for treating de... Read More


US Patent Issued to United Arab Emirates University on April 21 for "Peptide inhibitors targeting methyltransfer mechanism of SARS-CoV-2" (Emirati Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,423, issued on April 21, was assigned to United Arab Emirates University (Al Ain, United Arab Emirates). "Peptide inhibitors targeting met... Read More


US Patent Issued to The UAB Research Foundation on April 21 for "Treatment and prevention of pulmonary injury" (Alabama Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,424, issued on April 21, was assigned to The UAB Research Foundation (Birmingham, Ala.). "Treatment and prevention of pulmonary injury" wa... Read More


US Patent Issued to OXFORD UNIVERSITY INNOVATION on April 21 for "TNF muteins and uses thereof" (British Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,425, issued on April 21, was assigned to OXFORD UNIVERSITY INNOVATION Ltd. (Oxford, Great Britain). "TNF muteins and uses thereof" was inv... Read More


US Patent Issued to G2GBIO on April 21 for "Pharmaceutical comprising sustained-release microspheres including GLP-1 analogue or pharmaceutically acceptable salt thereof" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,426, issued on April 21, was assigned to G2GBIO INC. (Daejeon, South Korea). "Pharmaceutical comprising sustained-release microspheres inc... Read More


US Patent Issued to RED MOUNTAIN MED SPA on April 21 for "Sublingual semaglutide-BPC 157 combination for weight loss" (Arizona Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,427, issued on April 21, was assigned to RED MOUNTAIN MED SPA LLC (Scottsdale, Ariz.). "Sublingual semaglutide-BPC 157 combination for wei... Read More


US Patent Issued to The General Hospital, Whitehead Institute for Biomedical Research on April 21 for "Kinase NEK10 and its use in treating and diagnosing bronchiectasis and other respiratory disorders" (Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,428, issued on April 21, was assigned to The General Hospital Corp. (Boston) and Whitehead Institute for Biomedical Research (Cambridge, Ma... Read More


US Patent Issued to UNIVERSITY OF GEORGIA RESEARCH FOUNDATION on April 21 for "Proteins having pneumococcal capsule degrading activity and methods of use" (Georgia Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,429, issued on April 21, was assigned to UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC. (Athens, Ga.). "Proteins having pneumococcal capsu... Read More


US Patent Issued to RUIJIN HOSPITAL SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE on April 21 for "High-activity blood coagulation factor XI mutant Ala570Thr" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,430, issued on April 21, was assigned to RUIJIN HOSPITAL SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE (Shanghai). "High-activity blood ... Read More